Patent · US Active

LAR protein-specific ligand

US9365854B2 · kind B2 · utility

0Cited by

0References

20Claims

0Family size

Assignee

COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES · FR

Inventors

Frédéric Duconge · Sceaux, FR
Agnes Cibiel · Les Ulis, FR

Key dates

Filing date	Dec 15, 2011
Grant date	Jun 14, 2016
Priority date	—
Expiry date	Dec 15, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2310/3517
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to an aptamer comprising a nucleic acid comprising, or consisting of: —the sequence ACUGU CCCAG UAUGA CGCGA CUGCU UAGGU GGGAU GUUUC CCAUG CCUCG (SEQ ID NO: 1), or —a sequence comprising, or consisting of, at least 25 consecutive nucleotides in a sequence having at least 80% identity with SEQ ID NO: 1, with the proviso that a nucleic acid consisting of this sequence binds to the LAR protein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.